{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:17:31Z","timestamp":1794014251600,"version":"4.8.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"7","funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/cid\/cix510","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T19:11:33Z","timestamp":1496862693000},"page":"1094-1102","source":"Crossref","is-referenced-by-count":26,"title":["Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose"],"prefix":"10.1093","volume":"65","author":[{"given":"Sara","family":"Carazo Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta M","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"key\n\t\t\t\t20170914213544_CIT0001","volume-title":"Global measles and rubella strategic plan: 2012\u20132020","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20170914213544_CIT0002","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-3476(77)81036-6","article-title":"Further attenuated live measles vaccines: the need for revised recommendations","volume":"91","year":"1977","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t20170914213544_CIT0003","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.1977.03270310031003","article-title":"Measles immunization. Successes and failures","volume":"237","year":"1977","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170914213544_CIT0004","volume-title":"The immunological basis for immunization series. Module 7: measles. Update 2009","year":"2009"},{"key":"key\n\t\t\t\t20170914213544_CIT0005","first-page":"226","article-title":"Optimal age for vaccination against measles in the state of S\u00e3o Paulo, Brazil, taking into account the mother\u2019s serostatus","volume":"20","year":"2002","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0006","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.vaccine.2012.02.062","article-title":"Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad) in infants from 9 months of age","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0007","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1016\/j.vaccine.2007.06.020","article-title":"Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0008","volume-title":"Biannual measles and rubella monitoring reports","author":"European Centre for Disease Prevention and Control"},{"key":"key\n\t\t\t\t20170914213544_CIT0009","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jis923","article-title":"Largest measles epidemic in North America in a decade\u2014Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events","volume":"207","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0010","doi-asserted-by":"crossref","first-page":"30152","DOI":"10.2807\/1560-7917.ES.2016.21.9.30152","article-title":"The measles outbreak in Bulgaria, 2009\u20132011: an epidemiological assessment and lessons learnt","volume":"21","year":"2016","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170914213544_CIT0011","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2807\/esm.01.06.00186-en","article-title":"Outbreak of measles among adolescents, Belgium, 1996","volume":"1","year":"1996","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170914213544_CIT0012","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/jech.53.3.173","article-title":"Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine","volume":"53","year":"1999","journal-title":"J Epidemiol Community Health"},{"key":"key\n\t\t\t\t20170914213544_CIT0013","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/cid\/cis439","article-title":"Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12\u201314 months versus 15 months of age","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170914213544_CIT0015","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","article-title":"Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life","volume":"27","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170914213544_CIT0016","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0017","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","year":"2012","journal-title":"Eur J Pediatr"},{"key":"key\n\t\t\t\t20170914213544_CIT0018","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(12)61461-5","article-title":"Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170914213544_CIT0019","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0020","volume-title":"Applied longitudinal analysis","year":"2011","edition":"2nd ed"},{"key":"key\n\t\t\t\t20170914213544_CIT0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","article-title":"Duration of live measles vaccine-induced immunity","volume":"9","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170914213544_CIT0022","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(07)60107-X","article-title":"Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170914213544_CIT0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/166.1.205","article-title":"Persistence of measles antibody after revaccination","volume":"166","year":"1992","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0024","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170914213544_CIT0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/323346","article-title":"Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months","volume":"184","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0026","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1086\/378691","article-title":"Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age","volume":"189","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0027","first-page":"3134","article-title":"Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9\u201311, 12\u201314 or 15\u201317 months of age","volume":"18","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0028","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/peds.77.4.471","article-title":"Impact of revaccinating children who initially received measles vaccine before 10 months of age","volume":"77","year":"1986","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170914213544_CIT0029","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.vaccine.2005.01.092","article-title":"Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age","volume":"23","year":"2005","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170914213544_CIT0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/jcm.33.4.811-815.1995","article-title":"Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody","volume":"33","year":"1995","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170914213544_CIT0031","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/infdis\/168.6.1596-a","article-title":"Maternal measles and rubella antibody levels and serologic response in infants immunized with MMR II vaccine at 12 months of age","volume":"168","year":"1993","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0032","volume-title":"Correlates of vaccine-induced protection: methods and implications","author":"World Health Organization","year":"2013"},{"key":"key\n\t\t\t\t20170914213544_CIT0033","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/infdis\/172.6.1591","article-title":"Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination","volume":"172","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0034","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","year":"1990","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/infdis\/154.5.858","article-title":"Vaccinated children get milder measles infection: a community study from Guinea-Bissau","volume":"154","year":"1986","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170914213544_CIT0036","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)02364-2","article-title":"Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170914213544_CIT0037","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/oxfordjournals.aje.a009951","article-title":"Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity","volume":"150","year":"1999","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170914213544_CIT0038","first-page":"40","article-title":"A comparison of postelimination measles epidemiology in the United States, 2009\u20132014 versus 2001\u20132008","volume":"6","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key\n\t\t\t\t20170914213544_CIT0039","doi-asserted-by":"crossref","first-page":"ofv048","DOI":"10.1093\/ofid\/ofv048","article-title":"Measles in Canada between 2002 and 2013","volume":"2","year":"2015","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/7\/1094\/19918756\/cix510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T01:05:52Z","timestamp":1750295152000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/65\/7\/1094\/3862718\/Reduced-Antibody-Response-to-Infant-Measles"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,6,8]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix510","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}